On this page

    The 2026 Prohibited List comes into effect on 1 January 2026.

    An update on changes to the List is included in Sport Integrity Australia’s 2025 Annual Update course for athletes and support personnel.

    Prohibited List 2026 Annual Update

     

    Major modifications for 2026

    Substances and methods prohibited at all times (In- and Out-of-Competition)

    Prohibited substances

    S1. Anabolic agents
    • It was clarified in S1.1. that esters of the prohibited steroids are also prohibited.
    S2. Peptide hormones, growth factors, related substances, and mimetics
    • Pegmolesatide was added as an example of a new EPO-mimetic agent.
    S3. Beta-2 Agonists
    • The dosing intervals of salmeterol were revised to avoid potential ergogenic effects beyond therapeutic action1.
    • The maximum delivered dose per day is unchanged at 200 micrograms over 24 hours.
    S4. Hormone and Metabolic Modulators
    • 2-Phenylbenzo[h]chromen-4-one, also known as ɑ-naphthoflavone or 7,8-benzoflavone, was added as an example of an aromatase inhibitor. This synthetic substance has been found in supplements.
    • 5-N,6-N-bis(2-fluorophenyl)-[1,2,5]oxadiazolo[3,4-b]pyrazine-5,6-diamine, also known as BAM15, was added as an example of an activator of the AMP-activated protein kinase (AMPK). This synthetic substance has been found in supplements.

    Prohibited methods

    M1. Manipulation of Blood and Blood Components
    • It was clarified that withdrawal of blood or blood components is prohibited except for 1) analytical purposes including medical tests or Doping Control, or for 2) donation purposes performed in a collection center accredited by the relevant regulatory authority of the country in which it operates. Note that Platelet-Rich Plasma (PRP) and related procedures remain not prohibited.
    • The non-diagnostic use of carbon monoxide (CO) was added to the Prohibited Methods as a new section, M 1.4. It can increase erythropoiesis under certain conditions. The use of carbon monoxide for diagnostic purposes, such as total haemoglobin mass measurements or the determination of pulmonary diffusion capacity, is not prohibited. The current wording was chosen to differentiate between illicit use and the intake resulting from natural combustion processes (e.g. smoking), the environment (e. g. exhaust gases) or diagnostic procedures.
    M3. Gene and Cell Doping
    • Cell components (e.g. nuclei and organelles such as mitochondria and ribosomes) are added to the existing prohibition of using normal or genetically modified cells.

    Substances and methods prohibited In-Competition

    Prohibited substances

    S6. Stimulants
    • 2-[Bis(4-fluorophenyl)methylsulfinyl]acetamide (flmodafinil) and 2-[bis(4-fluorophenyl) methylsulfinyl]-N-hydroxyacetamide (fladrafinil) were added to the S6.A list of nonspecified stimulants. These unapproved substances are potent analogs of modafinil and adrafinil, which are already prohibited, and are sold as supplements.
    S9. Glucocorticoids
    • The following clarification is added as a footnote to the Glucocorticoid Washout Table (copied below): “Use of sustained-release glucocorticoid formulations may result in detectable glucocorticoid levels past the washout period due to prolonged systemic absorption.”
    Route Glucocorticoid  Washout period*
    Oral** All glucocorticoids 3 days
      Except: triamcinolone, triamcinolone acetonide. 10 days
    Intramuscular*** Betamethasone, dexamethasone, methylprednisolone. 5 days
      Prednisolone, prednisone. 10 days
      Triamcinolone acetonide 60 days

    Local injections***

    (including periarticular, intra-articular, peritendinous and intratendinous)

    		 All glucocorticoids 3 days
      Except: prednisolone, prednisone, triamcinolone acetonide, triamcinolone hexacetonide. 10 days
    Rectal All glucocorticoids 3 days
      Except: triamcinolone diacetate, triamcinolone acetonide. 10 days

     

    *The ‘washout period’ refers to the time from the last administered dose to the time of the start of the In-Competition period (i.e. beginning at 11:59 pm on the day before a Competition in which the Athlete is scheduled to participate, unless a different period was approved by WADA for a given sport). This is to allow elimination of the glucocorticoid to below the reporting level.

    **Oral routes also include e.g. oromucosal, buccal, gingival and sublingual.

    ***Use of sustained-release glucocorticoid formulations may result in detectable glucocorticoid levels past the washout period due to prolonged systemic absorption.

    • The Washout Period Table can be found in the Glucocorticoids and Therapeutic Use Exemptions Guidelines on the WADA website

    Monitoring Program

    • It is clarified that the urine monitoring of semaglutide includes also the monitoring of tirzepatide.

     

    Information for you